Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome

This study has been completed.
Information provided by (Responsible Party):
Hemispherx Biopharma Identifier:
First received: September 16, 2005
Last updated: April 16, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2004
  Primary Completion Date: February 2004 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):